Connection
Edwin deZoeten to Fibroblasts
This is a "connection" page, showing publications Edwin deZoeten has written about Fibroblasts.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.365 |
|
|
|
-
de Zoeten EF, Markovic D, Cohen EP. An optimum anti-melanoma response in mice immunized with fibroblasts transfected with DNA from mouse melanoma cells requires the expression of both syngeneic and allogeneic MHC-determinants. Gene Ther. 2002 Sep; 9(17):1163-72.
Score: 0.149
-
de Zoeten E, Carr-Brendel V, Markovic D, Taylor-Papadimitriou J, Cohen EP. Treatment of breast cancer with fibroblasts transfected with DNA from breast cancer cells. J Immunol. 1999 Jun 01; 162(11):6934-41.
Score: 0.119
-
de Zoeten EF, Li D, Cohen EP. Tumor immunity in mice immunized with fibroblasts transfected with tumor DNA. Adv Exp Med Biol. 2001; 495:393-401.
Score: 0.033
-
Glick RP, Lichtor T, de Zoeten E, Deshmukh P, Cohen EP. Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2. Neurosurgery. 1999 Oct; 45(4):867-74.
Score: 0.030
-
de Zoeten EF, Carr-Brendel V, Cohen EP. Resistance to melanoma in mice immunized with semiallogeneic fibroblasts transfected with DNA from mouse melanoma cells. J Immunol. 1998 Mar 15; 160(6):2915-22.
Score: 0.027
-
Xu W, de Zoeten E, Carr-Brendel V, Cohen EP. Co-expression of immunogenic determinants by the same cellular immunogen is required for the optimum immunotherapeutic benefit in mice with melanoma. Cancer Immunol Immunother. 1998 Jan; 45(5):217-24.
Score: 0.007